ImevaX develops vaccines against immune evasion factors.
Business Model:
Revenue: $0
Employees: 11-50
Address: Grillparzerstr. 18
City: Munich
State: bavaria
Zip: 81675
Country: DE
ImevaX develops vaccines against immune evasion factors.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2014 | Grant | 1 | $7.7M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
10/2014 | Series A | $0 |
BioMedPartners EMBL Ventures Santo Venture Capital Wellington Partners BioMedPartners EMBL Ventures Santo Venture Capital Wellington Partners |
10/2014 | Series A | $9.5M |
EMBL Ventures Biomed Partners Wellington Partners Venture Capital |
3/2015 | Series A | - | 3/2015 | Series A | - | 10/2014 | Series A | 4 | $9.6M |
BioMedPartners EMBL Ventures Santo Venture Capital Wellington Partners BioMedPartners EMBL Ventures Santo Venture Capital Wellington Partners |
9/2014 | Grant | 1 | $7.7M |
German Federal Ministry of Education and Research (BMBF) German Federal Ministry of Education and Research (BMBF) |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|